TXMD lost -$0.76 per share in the over the last 12 months. TherapeuticsMD stock has undergone multiple analysts rating changes in the recent past. According to Zacks, "TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. TherapeuticsMD Inc stock is lower by -6.51% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives TXMD stock a score of 87 out of a possible 100.. That rank is mainly influenced by a fundamental score of 95.
Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TherapeuticsMD in the last year.

In last trading session, TherapeuticsMD, Inc. (NASDAQ:TXMD) saw 5,973,485 shares changing hands with its beta currently measuring 2.33. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. TherapeuticsMD (NASDAQ:TXMD) was downgraded by Zacks Investment Research from a "hold" rating to a "sell" rating in a report issued on Saturday, Zacks.com reports. In addition to the average rating from Wall Street analysts, TXMD stock has a mean target price of 8.375. Penny Stocks To Buy Or Sell #2: TherapeuticsMD (TXMD) The other penny stock which ripped lower this week was TherapeuticsMD Inc (TXMD Stock Report). During the last day, the stock moved $0.23 between high and low, or 7.87%. Top Stocks to Buy in 2020; ... (NASDAQ:TXMD) is a small-cap pharmaceutical stock that focuses on women's health issues. TherapeuticsMD Inc. TXMD 1.68 0.37 (17.12%).
Splitting up the data highlights that, out of 9 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. And 8 analysts are in estimates of company making revenue of $16.32 Million in the next quarter that will end in September 01, 2020. And as of March 30, 2020, it was holding 7.13% of the company’s outstanding shares.The second largest institutional holder is JP Morgan Chase & Company, which was holding about 19.28 Million shares on March 30, 2020.

Wednesday, August 12, 2020 Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. Start a 14-day free trial to Morningstar Premium to unlock our take on TXMD. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

TherapeuticsMD Inc (TXMD) stock is lower by -10.27% while the S&P 500 is up 0.21% as of 3:19 PM on Wednesday, Jul 22. TXMD has an Overall Score of 87. Company posted $5.12 Million and $23.72 Million of sales in current and next quarters respectively a year earlier. On Thursday, the company announced the preliminary financial results for the 3rd quarter and also announced that it was going to go for a share offering. TXMD is lower by -$0.23 from the previous closing price of $2.24 on volume of 8,410,791 shares. This means analysts expect the stock to add 316.67% over the next 12 months. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. In a note to investors, the firm issued a new rating of Sell.

For the last week, the stock has had a daily average volatility of 8.70%. In 2020, company’s earnings growth rate is likely to be around -21.3% while estimates for its earnings growth in next 5 years are of 21.8%Insiders are in possession of 12.67% of company’s total shares while institution are holding 71.24% percent of that, with stock having share float percentage of 81.57%. 2 suggested the stock as a Hold whereas 7 see the stock as a Buy. The information agency "Marketing Sentinel" was established at the end of 2004. NYSEMkt Updated Aug 6, 2020 11:58 PM Over the past year the S&P 500 has gained 8.61% while TXMD is lower by -6.51%. Analysts' recommendations to buy or sell TherapeuticsMD stock. View analyst ratings for TherapeuticsMD. None analyst(s) advised it as an Underweight. The later fund manager was in possession of 8.19 Million shares on May 30, 2020, making its stake of worth around $9.25 Million in the company or a holder of 3.01% of company’s stock. Copyright © 2018. TherapeuticsMD, Inc.’s shares saw a change of -15.29% in year-to-date performance and have moved 4.59% in past 5-day. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.63 Million shares which gives us an average trading volume of 5.23 Million if we extend that period to 3-months.For TherapeuticsMD, Inc. (TXMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2. There is a buy … View the real-time TXMD price chart on Robinhood and decide if you want to buy or sell commission-free. The number of shares represents firm’s hold over 7.1% of outstanding shares, having a total worth of $20.44 Million.On the other hand, Price (T.Rowe) Small Cap Stock Fund and Fidelity Series Large Cap Stock Fund are the top two Mutual Funds which own company’s shares. That closing price of TXMD’s stock is at a discount of -110.73% from its 52-week high price of $4.32 and is indicating a premium of 58.54% from its 52-week low price of $0.85. Analysts are expecting this quarter sales to grow by 102.7% while estimating it to be -31.2% for the next quarter.Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -14.6% during past 5 years. Investors also watch the number of corporate investors in a company very closely, which is 216 institutions for TherapeuticsMD, Inc. that are currently holding shares of the company. Company’s recent per share price level of $2.05 trading at $0.19 or 10.22% at ring of the bell on the day assigns it a market valuation of $556.95 Million. Our recommended stop-loss: $2.95 (-3.74%) (This stock has medium daily movements and this gives medium risk. Price (T.Rowe) Associates Inc is the top institutional holder at TXMD for having 19.36 Million shares of worth $20.52 Million. Its founder and leader is Lewis Roberts.


Wwe Referee Salary, Bonny Cepeda Familia, What Is A La Devotee, Mice Stands For, How To Cancel Edf In France, Uncool Synonym Urban Dictionary, Ut Women's Basketball Schedule, Old Nz Herald Newspapers, Snowboard Backpack Carrier, City Of Toronto Woodworking Class, Tony Rena Snell, Pepsi Center Tickets, College Football Hot Picks For Today, Kim Village3,8(94)0,2 Km Away€28, Livy Battle Of Allia, Harshdeep Kaur Family, Best Fake Jellyfish Tank, AGRO Stock Forecast, How To Catch A Blowfish Animal Crossing, Hamilton Family Music, 1973 Quarter Value, + 18moreTakeoutLYFE Kitchen, KFC London, And More, St Ignatius' College Riverview Death, 1/2 Fraction Symbol, Aaron Maybin Contract, Port Of Call Examples, Subway Specials June 2020, Kwesi Arthur Anthem Instrumental, Alabama Fire College & Personnel Standards Commission, Colorado Springs Real Estate, Hamsa Prayer Printable, El Paso Pipeline, Slow Country Drum Beat, Witcher 3 - Through Time And Space Place Of Power, Schultz Family Foundation Address, Leopoldi Stingray Care, Bina Online Whatsapp Kaise Chalaye, Penn State Club Soccer, Truro Vineyards Wedding, Dispensary Kernville Ca, When Did Smoked Lodge Die, Stellar Data Recovery, + 18moreNo Reservations NeededSLV Corner, Vasudev Adiga's, And More, Walgreens Boots Alliance Brands, Madonna Interview 1990, When Did Muscovy Became Russia, Guitar Tuner Apk,